Toward Minimal Residual Disease-Directed Therapy in Melanoma

Florian Rambow, Aljosja Rogiers, Oskar Marín-Béjar, +22

Cell

Novel TherapyMedicineMelanomaDermatologyOncology +2

Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals

Jessica Cedervall, Yanyu Zhang, Hua Huang, +4

Cancer Research

Tumor InnervationImmunologyImmune RegulationPathologyImmunoediting +24

IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin

Ryan S. Lane, Julia Femel, Alec P. Breazeale, +7

The Journal of Experimental Medicine

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Oskar Marín-Béjar, Aljosja Rogiers, Michael Dewaele, +22

Cancer Cell

Health SciencesSkin CancerTumor HeterogeneityGeneticsMelanoma +5

T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control

Maria M. Steele, Abhinav Jaiswal, Ines Delclaux, +11

Nature Immunology

Limits Tumor ControlCancer ImmunosurveillanceT-regulatory CellImmunologyT Cell Egress +9

Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer

Julia Femel, Elisabeth J. M. Huijbers, Falk Saupe, +9

Oncotarget

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapy

Elisabeth J. M. Huijbers, Maria Ringvall, Julia Femel, +5

The FASEB Journal

ImmunologyPathologyImmune SystemImmunotherapySynthetic Immunology +17

The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development

Elisabeth J. M. Huijbers, Julia Femel, Karl Andersson, +3

Vaccine

VaccinationOncologyMedicineImmunologyTherapeutic Vaccine +11

Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma

Ananya Roy, Julia Femel, Elisabeth J. M. Huijbers, +5

PLoS ONE

Breast OncologyEndocrine-related CancerMalignant DiseaseMedicineSerglycin Proteoglycans +11

Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters

Falk Saupe, Elisabeth J. M. Huijbers, Tobias Hein, +4

The FASEB Journal

ImmunologyPathologyImmunotherapeuticsImmunotherapyTumor Immunology +16